Healthcare provider profile · identity verified

David M Larrabee, MD

Family Practice · WORCESTER, MA · NPI 1063423010

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	602	164
Omeprazole	Omeprazole	361	91
Lisinopril	Lisinopril	347	96
Amlodipine Besylate	Amlodipine Besylate	310	87
Oxycodone Hcl	Oxycodone Hcl	296	29
Metformin Hcl	Metformin Hcl	258	72
Losartan Potassium	Losartan Potassium	246	66
Gabapentin	Gabapentin	228	44
Metoprolol Succinate	Metoprolol Succinate	222	58
Tamsulosin Hcl	Tamsulosin Hcl	207	66
Levothyroxine Sodium	Levothyroxine Sodium	183	47
Albuterol Sulfate Hfa	Albuterol Sulfate	181	49
Lorazepam	Lorazepam	162	35
Trazodone Hcl	Trazodone Hcl	158	25
Eliquis	Apixaban	153	29
Hydrochlorothiazide	Hydrochlorothiazide	150	40
Duloxetine Hcl	Duloxetine Hcl	147	36
Simvastatin	Simvastatin	147	40
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	129	27
Tramadol Hcl	Tramadol Hcl	124	20
Alprazolam	Alprazolam	123	16
Sertraline Hcl	Sertraline Hcl	121	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	115	14
Ibuprofen	Ibuprofen	113	27
Fluticasone Propionate	Fluticasone Propionate	112	34
Escitalopram Oxalate	Escitalopram Oxalate	111	26
Rosuvastatin Calcium	Rosuvastatin Calcium	105	32
Clonazepam	Clonazepam	103	14
Allopurinol	Allopurinol	96	24
Jardiance	Empagliflozin	95	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	92	11
Pravastatin Sodium	Pravastatin Sodium	90	25
Famotidine	Famotidine	81	20
Furosemide	Furosemide	78	20
Pantoprazole Sodium	Pantoprazole Sodium	78	20
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	75	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	66	12
Naproxen	Naproxen	63	12
Diazepam	Diazepam	62	12
Metformin Hcl Er	Metformin Hcl	62	18
Atenolol	Atenolol	52	15
Celecoxib	Celecoxib	52	suppressed
Methadone Hcl	Methadone Hcl	48	suppressed
Ozempic	Semaglutide	48	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	16
Bupropion Xl	Bupropion Hcl	46	21
Mirtazapine	Mirtazapine	46	14
Triamcinolone Acetonide	Triamcinolone Acetonide	45	30
Ondansetron Hcl	Ondansetron Hcl	43	13
Alendronate Sodium	Alendronate Sodium	42	suppressed
Ventolin Hfa	Albuterol Sulfate	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Pregabalin	Pregabalin	38	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	36	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	34	suppressed
Potassium Chloride	Potassium Chloride	33	suppressed
Amoxicillin	Amoxicillin	32	21
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Nystatin	Nystatin	32	suppressed
Azithromycin	Azithromycin	31	23
Buspirone Hcl	Buspirone Hcl	31	suppressed
Prednisone	Prednisone	31	18
Trulicity	Dulaglutide	31	suppressed
Doxepin Hcl	Doxepin Hcl	30	suppressed
Lovastatin	Lovastatin	30	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	11
Lidocaine	Lidocaine	29	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Baclofen	Baclofen	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Mounjaro	Tirzepatide	27	suppressed
Topiramate	Topiramate	27	suppressed
Glipizide Er	Glipizide	26	suppressed
Carisoprodol	Carisoprodol	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	11
Ketoconazole	Ketoconazole	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Brilinta	Ticagrelor	17	suppressed
Carvedilol	Carvedilol	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	16
Ezetimibe	Ezetimibe	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Glipizide	Glipizide	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Ramipril	Ramipril	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Colchicine	Colchicine	14	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Novolog Flexpen	Insulin Aspart	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Travoprost	Travoprost	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Buprenorphine	Buprenorphine	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Minocycline Hcl	Minocycline Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error